Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK LIGORSKI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1659465003
CMS profile
302472
Location
NORWALK, CT

General Payments · PY2018–2024

$7,611.39

  • Reported across 231 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,935.43

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,000.00 1
Food and Beverage $895.90 33
Travel and Lodging $39.53 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $908.93 31
PY2019 $546.52 18
PY2020 $339.61 14
PY2021 $793.93 43
PY2022 $1,225.11 50
PY2023 $861.86 40
PY2024 $2,935.43 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.61 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104882033 CMS
ABBVIE INC. $34.87 05/09/2024 Food and Beverage Undisputed 01/23/2026 1104882035 CMS
ABBVIE INC. $15.90 06/12/2024 Food and Beverage Undisputed 01/23/2026 1104882037 CMS
ABBVIE INC. $11.61 07/09/2024 Food and Beverage Undisputed 01/23/2026 1104882039 CMS
ABBVIE INC. $26.20 08/06/2024 Food and Beverage Undisputed 01/23/2026 1104882041 CMS
ABBVIE INC. $31.89 08/07/2024 Food and Beverage Undisputed 01/23/2026 1104882043 CMS
ABBVIE INC. $24.61 10/16/2024 Food and Beverage Undisputed 01/23/2026 1104882045 CMS
ABBVIE INC. $123.89 12/02/2024 Food and Beverage Undisputed 01/23/2026 1104882047 CMS
Axsome Therapeutics, Inc. $81.71 09/05/2024 Food and Beverage Undisputed 01/23/2026 1148301730 CMS
Axsome Therapeutics, Inc. $39.53 09/05/2024 Travel and Lodging Undisputed 01/23/2026 1148301732 CMS
Axsome Therapeutics, Inc. $2,000.00 09/05/2024 Consulting Fee Undisputed 01/23/2026 1148301734 CMS
Axsome Therapeutics, Inc. $23.02 09/25/2024 Food and Beverage Undisputed 01/23/2026 1148301726 CMS
Axsome Therapeutics, Inc. $14.61 12/18/2024 Food and Beverage Undisputed 01/23/2026 1148301728 CMS
Bausch Health US, LLC $18.06 07/31/2024 Food and Beverage Undisputed 01/23/2026 1148022036 CMS
Corium, LLC $31.62 04/23/2024 Food and Beverage Undisputed 01/23/2026 1100073383 CMS
Corium, LLC $22.74 09/04/2024 Food and Beverage Undisputed 01/23/2026 1100185663 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.53 03/11/2024 Food and Beverage Undisputed 01/23/2026 1143265675 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.66 07/17/2024 Food and Beverage Undisputed 01/23/2026 1143265679 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.00 11/20/2024 Food and Beverage Undisputed 01/23/2026 1143265682 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.07 12/05/2024 Food and Beverage Undisputed 01/23/2026 1143265686 CMS
Lundbeck LLC $28.65 08/28/2024 Food and Beverage Undisputed 01/23/2026 1145939720 CMS
Neurocrine Biosciences, Inc. $17.13 05/29/2024 Food and Beverage Undisputed 01/23/2026 1150868434 CMS
Neurocrine Biosciences, Inc. $28.47 10/09/2024 Food and Beverage Undisputed 01/23/2026 1150829556 CMS
Neurocrine Biosciences, Inc. $30.57 11/26/2024 Food and Beverage Undisputed 01/23/2026 1150825024 CMS
Otsuka America Pharmaceutical, Inc. $23.06 07/25/2024 Food and Beverage Undisputed 01/23/2026 1118930846 CMS
Otsuka America Pharmaceutical, Inc. $17.50 08/20/2024 Food and Beverage Undisputed 01/23/2026 1118930848 CMS
Otsuka America Pharmaceutical, Inc. $21.04 12/16/2024 Food and Beverage Undisputed 01/23/2026 1118930850 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.67 08/14/2024 Food and Beverage Undisputed 01/23/2026 1137620533 CMS
Teva Pharmaceuticals USA, Inc. $21.57 01/02/2024 Food and Beverage Undisputed 01/23/2026 1151619784 CMS
Teva Pharmaceuticals USA, Inc. $23.61 06/19/2024 Food and Beverage Undisputed 01/23/2026 1151619850 CMS
Teva Pharmaceuticals USA, Inc. $16.06 07/31/2024 Food and Beverage Undisputed 01/23/2026 1151619868 CMS
Teva Pharmaceuticals USA, Inc. $14.79 10/23/2024 Food and Beverage Undisputed 01/23/2026 1151619876 CMS
Teva Pharmaceuticals USA, Inc. $20.31 11/13/2024 Food and Beverage Undisputed 01/23/2026 1151619882 CMS
Vanda Pharmaceuticals Inc. $33.77 11/21/2024 Food and Beverage Undisputed 01/23/2026 1133910456 CMS
Vanda Pharmaceuticals Inc. $16.10 12/11/2024 Food and Beverage Undisputed 01/23/2026 1133910458 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.